Glucose Health Stock Price To Earning
| GLUC Stock | USD 0.16 0.01 6.67% |
Glucose Health fundamentals help investors to digest information that contributes to Glucose Health's financial success or failures. It also enables traders to predict the movement of Glucose Pink Sheet. The fundamental analysis module provides a way to measure Glucose Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Glucose Health pink sheet.
Glucose |
Glucose Health Company Price To Earning Analysis
Glucose Health's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Glucose Health Price To Earning | (1.99) X |
Most of Glucose Health's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glucose Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Glucose Health has a Price To Earning of -1.99 times. This is 109.49% lower than that of the Consumer Defensive sector and 107.96% lower than that of the Packaged Foods industry. The price to earning for all United States stocks is 106.93% higher than that of the company.
Glucose Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Glucose Health's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Glucose Health could also be used in its relative valuation, which is a method of valuing Glucose Health by comparing valuation metrics of similar companies.Glucose Health is currently under evaluation in price to earning category among its peers.
Glucose Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (0.32) % | |||
| Operating Margin | (0.32) % | |||
| Current Valuation | 1.16 M | |||
| Shares Outstanding | 4.55 M | |||
| Shares Owned By Insiders | 10.14 % | |||
| Shares Owned By Institutions | 0.25 % | |||
| Price To Earning | (1.99) X | |||
| Price To Sales | 3.42 X | |||
| Revenue | 1.11 M | |||
| Gross Profit | (2.41 K) | |||
| EBITDA | (336.06 K) | |||
| Net Income | (338.9 K) | |||
| Cash And Equivalents | 569.39 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 332.88 K | |||
| Current Ratio | 545.85 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (72.74 K) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 3.12 | |||
| Market Capitalization | 2.68 M | |||
| Total Asset | 207 K | |||
| Retained Earnings | (5.96 M) | |||
| Working Capital | (217 K) | |||
| Current Asset | 207 K | |||
| Current Liabilities | 424 K | |||
| Z Score | -33.9 |
About Glucose Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Glucose Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glucose Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glucose Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Glucose Pink Sheet
Glucose Health financial ratios help investors to determine whether Glucose Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Glucose with respect to the benefits of owning Glucose Health security.